MedTrace Logo

Pre-Exercise for Allogeneic Stem Cell Transplant Patients

NCT03080792 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 14

Last updated 2021-06-04

No results posted yet for this study

Summary

The PRESENT-P study is a one-arm exercise intervention study for hematological cancer patients prior allogeneic stem cell transplantation (allo-HCT). This pilot study will investigate in a prehabilitation approach the safety and feasibility of high-intensity exercise program directly prior transplantation.

Conditions

  • Cancer, Hematological

Interventions

BEHAVIORAL

Experimental: moderate to high-intensity exercise

2x per week endurance exercise (continuous moderate and high intensity intervall training on a cycle ergometer) and progressive resistance training (machine based hypertrophy training)

Sponsors & Collaborators

  • University Hospital Freiburg

    collaborator OTHER

  • University of Cologne

    collaborator OTHER

  • University Hospital Dresden

    collaborator OTHER

  • University Hospital Heidelberg

    lead OTHER

Principal Investigators

  • Joachim Wiskemann, Dr. · Heidelberg University Hospital, National Center for Tumor Disease, Division of Medical Oncology, Working Group Exercise Oncology

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-11-30
Primary Completion
2018-12-31
Completion
2019-06-30

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03080792 on ClinicalTrials.gov